preliminary PROGRAM |
| Sunday, September 9, 2007 |
| 17.00 - 17.30 |
Opening Ceremony - Course presentation |
| 17.30 - 18.00 |
Pathogenesis of SLE - J.R. Kalden |
| 18.00 - 18.30 |
The clinical spectrum of SLE: SLE, overlap syndromes, MCTD - J.S. Smolen |
|
| Monday, September 10, 2007 |
| |
Therapy of SLE: traditional drugs and new prospective |
| 09.00 - 09.30 |
The role of pharmacogenomics in the treatment of SLE - R. Danesi |
| 09.30 - 10.00 |
Corticosteroids and SLE - M. Cutolo |
| 10.00 - 10.45 |
“Traditional drugs” in SLE. Focus on immunosuppressive drugs - M. Mosca |
| 10.45 - 11.15 |
Coffee break |
| 10.15 - 11.45 |
Biological agents in SLE - M. Aringer |
| 11.15 - 12.15 |
Statins, anticoagulant, antithrombotic drugs - P.L. Meroni |
| 12.15 - 12.45 |
Can we further improve SLE prognosis? - A. Doria |
| 13.00 - 14.30 |
Lunch |
| 14.30 - 15.00 |
Drug therapy and prevention of infertility in SLE - A.G. Tzioufas |
| 15.00 - 15.30 |
Drug therapy and osteoporosis in SLE - M. Mazzantini |
| 15.30 - 16.00 |
Drug therapy and toxicity in pregnancy and lactation - M. Ostensen |
|
| Tuesday, September 11, 2007 |
| |
CNS involvement |
| 09.00 - 09.30 |
CNS lupus, autoantibodies, smell and pathogenesis - Y. Shoenfeld |
| 09.30 - 10.00 |
Pathogenesis of CNS involvement in SLE - G. Riemekasten |
| 10.00 - 10.30 |
Neurological manifestations of CNS involvement in SLE - J.C. Piette |
| 10.30 - 10.45 |
Coffee break |
| 10.45 - 11.15 |
Optimizing the clinical monitoring of CNS involvement in SLE - G. Castellino |
| 11.15 - 11.45 |
Therapeutic algorhytms in neurological involvement in SLE - G.M. Steup Beekman |
| 11.45 - 12.05 |
PRACTICAL POINT: The development of a questionnaire to assess neurological involvement in SLE patients |
| 12.05 - 13.00 |
Discussion of clinical cases |
| 13.00 - 14.30 |
Lunch |
| |
The challenging aspects of lupus I |
| 14.30 - 15.00 |
Fever and SLE - C.M. Montecucco |
| 15.00 - 15.30 |
Haematological manifestations of SLE - R. Voll |
| 15.30 - 16.00 |
Gastrointestinal and liver involvement in SLE - R. Priori |
| 16.00 - 16.30 |
Juvanile Lupus - A. Martini |
| 16.30 - 17.30 |
PRACTICAL POINT: Which role for computerized data bases in the assessment of patients? |
|
| Wednesday, September 12, 2007 |
| |
Measures to assess and monitoring a patient with SLE and response to therapy: creation of a data base for SLE patients |
| 09.00 - 09.30 |
ACR classificative criteria: a critical review - H. Nossent |
| 09.30 - 10.00 |
The core set variables to assess patients in routine clinical practice - S. Bombardieri |
| 10.00 - 10.30 |
Disease activity and damage indices in SLE, an overview - M. Ward |
| 10.30 - 10.45 |
Coffee break |
| 10.45 - 11.15 |
EULAR Recommendations for clinical trials in SLE - C. Gordon |
| 11.15 - 11.45 |
EULAR Recommendations for the management of SLE - D. Boumpas |
| 11.45 - 12.15 |
Adult stem cell transplantation in autoimmune disease – an update - A. Tyndall |
| 12.15 - 12.45 |
Discussion of 2 clinical cases |
| Afternoon |
Free |
|
| Thursday, September 13, 2007 |
| |
Kidney involvement |
| 09.00 - 09.30 |
Pathogenetic autoantibodies in lupus nephritis - P. Migliorini |
| 09.30 - 10.00 |
Histological features of lupus nephritis - G. Moroni |
| 10.00 - 10.30 |
Clinical features and prognostic factors in LN - R.A. Sinico |
| 10.30 - 10.45 |
Coffee break |
| 10.45 - 11.15 |
Dyalisis and kidney transplantation in SLE - J. Berden |
| 11.15 - 11.45 |
Therapeutic algorhytms in lupus nephritis - D. Boumpas |
| 11.45 - 13.00 |
Discussion of clinical cases |
| 13.00 - 14.30 |
Lunch |
| |
Skin involvement |
| 14.30 - 15.00 |
Overview of cutaneous manifestations in Lupus erythematosus - F. Nyberg |
| 15.00 - 15.30 |
Diagnosis and differential diagnosis of cutaneous involvement in Lupus Erythematosus - R. Rondinone |
| 15.30 - 16.00 |
Treatment of cutaneous manifestations of Lupus Erythematosus - A. Kuhn |
| 16.00 - 17.00 |
Discussion of 2 clinical cases |
|
| Friday, September 14, 2007 |
| |
The challenging aspects of lupus II |
| 09.00 - 09.30 |
Heart and lung in SLE - M. Schneider |
| 09.30 - 10.00 |
Joint involvement in SLE - M. Mosca, A. Delle Sedie |
| 10.00 - 10.30 |
Atherosclerosis in SLE - R. Gerli |
| 10.30 - 10.45 |
Coffee break |
| 10.45 - 11.15 |
Late onset SLE - P.C. Sarzi-Puttini |
| 11.15 - 11.45 |
Anti-phospholipid syndrome - G. Espinosa |
| 11.45 - 12.45 |
Discussion of clinical cases |
| 13.00 - 14.30 |
Lunch |
| |
Pregnancy and SLE |
| 14.30 - 15.15 |
Outcome of pregnancy and outcome of babies in patients with SLE - A. Tincani |
| 15.15 - 15.45 |
Neonatal lupus - A. Brucato |
| 15.45 - 16.15 |
Clinical exercise: key questions |
| 16.15 |
CONCLUSIVE REMARKS - S. Bombardieri |
|
